Salusin-alpha - a New Factor in the Pathogenesis of Lipid Abnormalities in Hemodialysis Patients

NCT01448174 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

310

Enrollment

OTHER

Sponsor class

Conditions

Renal Failure Chronic Requiring Hemodialysis
Metabolic Syndrome
Diabetes Mellitus Type 2
Hyperlipidemia

Interventions

DRUG: Atorvastatin

Sponsor

Poznan University of Medical Sciences